Stock Track | Owens & Minor Plummets 5.09% as Preliminary Results Show Losses, Acquisition Plans

Stock Track

2025/02/04

Owens & Minor Inc. (OMI) stock plummeted 5.09% during Tuesday's intraday trading session, following the company's preliminary financial results for the fourth quarter and full year 2024 that showed significant losses amid plans to acquire Rotech Healthcare Holdings.

The medical supplies distributor reported a projected net loss of $288 million to $311 million for the fourth quarter, largely due to a $310 million goodwill impairment charge related to its Apria subsidiary. Despite the losses, the company highlighted strong performance in its Patient Direct division, with consistent mid-single-digit growth over the past year.

For the full year 2024, Owens & Minor forecasts a net loss ranging from $355 million to $378 million, but revenue between $10.67 billion and $10.70 billion. The company also announced that it has begun raising funds to support its planned acquisition of Rotech Healthcare Holdings, with the deal expected to be finalized in the first half of 2025.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1147993558"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147993558\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147993558?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-04 23:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147993558","market":"hk","top_or_hot":-1,"title":"Stock Track | Owens & Minor Plummets 5.09% as Preliminary Results Show Losses, Acquisition Plans","media":"Stock Track","content":"<p>Owens & Minor Inc. (OMI) stock plummeted 5.09% during Tuesday's intraday trading session, following the company's preliminary financial results for the fourth quarter and full year 2024 that showed significant losses amid plans to acquire Rotech Healthcare Holdings.</p>\n\n<p>The medical supplies distributor reported a projected net loss of $288 million to $311 million for the fourth quarter, largely due to a $310 million goodwill impairment charge related to its Apria subsidiary. Despite the losses, the company highlighted strong performance in its Patient Direct division, with consistent mid-single-digit growth over the past year.</p>\n\n<p>For the full year 2024, Owens & Minor forecasts a net loss ranging from $355 million to $378 million, but revenue between $10.67 billion and $10.70 billion. The company also announced that it has begun raising funds to support its planned acquisition of Rotech Healthcare Holdings, with the deal expected to be finalized in the first half of 2025.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Owens & Minor Plummets 5.09% as Preliminary Results Show Losses, Acquisition Plans</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Owens & Minor Plummets 5.09% as Preliminary Results Show Losses, Acquisition Plans\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-02-04 23:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Owens & Minor Inc. (OMI) stock plummeted 5.09% during Tuesday's intraday trading session, following the company's preliminary financial results for the fourth quarter and full year 2024 that showed significant losses amid plans to acquire Rotech Healthcare Holdings.</p>\n\n<p>The medical supplies distributor reported a projected net loss of $288 million to $311 million for the fourth quarter, largely due to a $310 million goodwill impairment charge related to its Apria subsidiary. Despite the losses, the company highlighted strong performance in its Patient Direct division, with consistent mid-single-digit growth over the past year.</p>\n\n<p>For the full year 2024, Owens & Minor forecasts a net loss ranging from $355 million to $378 million, but revenue between $10.67 billion and $10.70 billion. The company also announced that it has begun raising funds to support its planned acquisition of Rotech Healthcare Holdings, with the deal expected to be finalized in the first half of 2025.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1147993558","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147993558","pubTimestamp":1738683071,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Owens & Minor Inc.  stock plummeted 5.09% during Tuesday's intraday trading session, following the company's preliminary financial results for the fourth quarter and full year 2024 that showed significant losses amid plans to acquire Rotech Healthcare Holdings.The medical supplies distributor reported a projected net loss of $288 million to $311 million for the fourth quarter, largely due to a $310 million goodwill impairment charge related to its Apria subsidiary. Despite the losses, the compan","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"股票追踪Owens&Minor暴跌5.09%，初步业绩显示亏损、收购计划","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMI":1},"content_text":"Owens & Minor Inc. (OMI) stock plummeted 5.09% during Tuesday's intraday trading session, following the company's preliminary financial results for the fourth quarter and full year 2024 that showed significant losses amid plans to acquire Rotech Healthcare Holdings.\nThe medical supplies distributor reported a projected net loss of $288 million to $311 million for the fourth quarter, largely due to a $310 million goodwill impairment charge related to its Apria subsidiary. Despite the losses, the company highlighted strong performance in its Patient Direct division, with consistent mid-single-digit growth over the past year.\nFor the full year 2024, Owens & Minor forecasts a net loss ranging from $355 million to $378 million, but revenue between $10.67 billion and $10.70 billion. The company also announced that it has begun raising funds to support its planned acquisition of Rotech Healthcare Holdings, with the deal expected to be finalized in the first half of 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"merge,movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}